Dabigatran Etexilate in Patients With Mechanical Heart Valves



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:11/11/2012
Start Date:October 2011
Contact:Boehringer Ingelheim Call Center
Email:clintriage.rdg@boehringer-ingelheim.com
Phone:1-800-243-0127

Use our guide to learn which trials are right for you!

A Randomised, Phase II Study to Evaluate the sAfety and Pharmacokinetics of oraL dabIGatran Etexilate in Patients After Heart Valve replacemeNt


To validate the dosing algorithm for dabigatran etexilate in patients receiving a mechanical
heart valve.


Inclusion criteria:

1. Patients aged 18-75

2. Patients who have received a bileaflet mechanical heart valve

Exclusion criteria:

1. Prior valve surgery

2. Uncontrolled hypertension

3. severe renal impairment

4. active liver disease

5. increased risk of bleeding
We found this trial at
6
sites
939
mi
from 91732
Tacoma, WA
Click here to add this to my saved trials
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Philadelphia, Pennsylvania
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
1227
mi
from 91732
Plano, TX
Click here to add this to my saved trials
1525
mi
from 91732
Rochester, MN
Click here to add this to my saved trials